Sodium Citrate

CHEMBL1355 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
258.1 g/mol
LogP
Phase
4

Sodium citrate is a citrate salt used as an alkalinizing agent, anticoagulant in blood collection, and pharmaceutical excipient with applications in urinary alkalinization for stone prevention, correction of metabolic acidosis, and as a bladder anticoagulant. In blood banking, it chelates calcium ions to prevent coagulation during blood collection and processing. Oral sodium citrate raises urinary pH to prevent and dissolve uric acid and cystine kidney stones.

Berat Molekul

258,0700 g/mol

TPSA

141,00 Ų

Area Terapeutik

Mekanisme Kerja

Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanisme

Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+]

InChI

InChI=1S/C6H8O7.3Na/c7-3(8)1-6(13,5(11)12)2-4(9)10;;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;/q;3*+1/p-3

Molecular Formula

C6H5Na3O7

HBD / HBA

1 / 7

Ikatan yang Dapat Dirotasi

2

Atom Berat

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

Sodium citrate is a citrate salt used as an alkalinizing agent, anticoagulant in blood collection, and pharmaceutical excipient with applications in urinary alkalinization for stone prevention, correction of metabolic acidosis, and as a bladder anticoagulant. In blood banking, it chelates calcium ions to prevent coagulation during blood collection and processing. Oral sodium citrate raises urinary pH to prevent and dissolve uric acid and cystine kidney stones.

Forms stable, water-soluble chelate complexes with specific metal ions, facilitating their excretion from the body through the kidneys. This reduces toxic metal burden in affected tissues.

Yes, Sodium Citrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1355. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6224. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.